Skip to main content
BIR Issuancesby BetterGov.phBeta
Official source
Browse issuances
Revenue Memorandum Circular · RMC

RMC No. 19-2023

To publish the January 4, 2023 letter from FDA Director General Samuel A. Zacate endorsing updates to the "List of VAT-Exempt Medicines" under Republic Act No. 11534 (CREATE Act), and to clarify the effectivity of the VAT exemption of the covered medicines and medical devices.

Bureau of Internal RevenueIndependent research copy
Document type
RMC
Number
19
Year
2023
Text quality
Not specified

Document text

Reference copy · verify against the official source
RMC No. 19-2023 (February 6, 2023) publishes a January 4, 2023 letter from FDA Director General Samuel A. Zacate endorsing updates to the "List of VAT-Exempt Medicines" under Republic Act No. 11534 (CREATE Act); the updated list now includes certain medicines and medical devices for COVID-19 treatment. Citing Q&A No. 1 of RMC No. 99-2021, the circular states that the VAT exemption of the covered medicines and medical devices takes effect on the date the FDA publishes the updates to the list.